IL6 and non-small cell lung carcinoma: Decreased TNF-α and IL-1 secretion has been demonstrated in AMs from patients with both NSCLC (squamous and large cell undifferentiated subtypes) and small cell lung cancer and reduced IL-6 secretion has been demonstrated from AMs derived from patients with large cell undifferentiated and small cell subtypes [15].